These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 21437528)

  • 1. Use of the ML-Flow test as a tool in classifying and treating leprosy.
    Contin LA; Alves CJ; Fogagnolo L; Nassif PW; Barreto JA; Lauris JR; Nogueira ME
    An Bras Dermatol; 2011; 86(1):91-5. PubMed ID: 21437528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Description of leprosy classification at baseline among patients enrolled at the uniform multidrug therapy clinical trial for leprosy patients in Brazil.
    Moura RS; Penna GO; Cardoso LP; de Andrade Pontes MA; Cruz R; de Sá Gonçalves H; Fernandes Penna ML; de Araújo Stefani MM; Bührer-Sékula S
    Am J Trop Med Hyg; 2015 Jun; 92(6):1280-4. PubMed ID: 25940192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Revalidation of various clinical criteria for the classification of leprosy--a clinic-pathological study.
    Gupta R; Kar HK; Bharadwaj M
    Lepr Rev; 2012 Dec; 83(4):354-62. PubMed ID: 23614253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicobacteriological evaluation of leprosy patients with 1-5 skin lesions.
    Ansari AS; Saxena K; Singh KK; Choudhary A; Singh A; Tripathi AK; Sharma V
    Int J Mycobacteriol; 2020; 9(2):209-211. PubMed ID: 32474546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of two rapid tests for anti-phenolic glycolipid-I serology in Brazil and Nepal.
    Stefani MM; Grassi AB; Sampaio LH; Sousa AL; Costa MB; Scheelbeek P; Neupane KD; Hagge DA; Macdonald M; Cho SN; Oskam L; Bührer-Sékula S
    Mem Inst Oswaldo Cruz; 2012 Dec; 107 Suppl 1():124-31. PubMed ID: 23283463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The ML flow test as a point of care test for leprosy control programmes: potential effects on classification of leprosy patients.
    Bührer-Sékula S; Visschedijk J; Grossi MA; Dhakal KP; Namadi AU; Klatser PR; Oskam L
    Lepr Rev; 2007 Mar; 78(1):70-9. PubMed ID: 17518099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of immunoglobulin isotypes against LID-1 and NDO-LID for, particularly IgG1, confirming the diagnosis of multibacillary leprosy.
    Marçal PHF; Fraga LAO; Mattos AMM; Menegati L; Coelho ADCO; Pinheiro RO; Sarno EN; Duthie MS; Teixeira HC
    Mem Inst Oswaldo Cruz; 2018; 113(5):e170467. PubMed ID: 29513821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Host immune responses induced by specific Mycobacterium leprae antigens in an overnight whole-blood assay correlate with the diagnosis of paucibacillary leprosy patients in China.
    Chen X; You YG; Yuan YH; Yuan LC; Wen Y
    PLoS Negl Trop Dis; 2019 Apr; 13(4):e0007318. PubMed ID: 31017900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance of serological tests PGL1 and NDO-LID in the diagnosis of leprosy in a reference Center in Brazil.
    Leturiondo AL; Noronha AB; do Nascimento MOO; Ferreira CO; Rodrigues FDC; Moraes MO; Talhari C
    BMC Infect Dis; 2019 Jan; 19(1):22. PubMed ID: 30616580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A rapid ELISA for the diagnosis of MB leprosy based on complementary detection of antibodies against a novel protein-glycolipid conjugate.
    Duthie MS; Raychaudhuri R; Tutterrow YL; Misquith A; Bowman J; Casey A; Balagon MF; Maghanoy A; Beltran-Alzate JC; Romero-Alzate M; Cardona-Castro N; Reed SG
    Diagn Microbiol Infect Dis; 2014 Jun; 79(2):233-9. PubMed ID: 24666703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of ML Flow serology and slit skin smears to assess the bacterial load in newly diagnosed leprosy patients in Brazil.
    Lyon S; Lyon AC; Da Silva RC; Grossi MA; Lyon SH; Bührer-Sékula S; Rocha MO
    Lepr Rev; 2008 Jun; 79(2):162-70. PubMed ID: 18711938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of a rapid serological test for leprosy classification using human serum albumin as the antigen carrier.
    Moura RS; Penna GO; Fujiwara T; Pontes MA; Cruz R; Gonçalves Hde S; Penna ML; Cardoso LP; Stefani MM; Bührer-Sékula S
    J Immunol Methods; 2014 Oct; 412():35-41. PubMed ID: 24983877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective study to validate various clinical criteria used in classification of leprosy: a study from a tertiary care center in India.
    Thapa M; Sendhil Kumaran M; Narang T; Saikia UN; Sawatkar GU; Dogra S
    Int J Dermatol; 2018 Sep; 57(9):1107-1113. PubMed ID: 29809278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leprosy serology (ML Flow test) in borderline leprosy patients classified as paucibacillary by counting cutaneous lesions: an useful tool.
    Barreto JA; Nogueira ME; Diorio SM; Bührer-Sékula S
    Rev Soc Bras Med Trop; 2008; 41 Suppl 2():45-7. PubMed ID: 19618075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serodiagnosis of paucibacillary and multibacillary leprosy using a recombinant chimeric protein composed of specific B-cell epitopes derived from Mycobacterium leprae proteins.
    Assis BPN; Chaves AT; Lage DP; Cardoso MM; Freitas CS; Pereira IAG; Câmara RSB; Martins VT; de Oliveira ALG; Machado-de-Ávila RA; Galdino AS; Chávez-Fumagalli MA; Christodoulides M; Gonçalves DU; Bueno LL; Fujiwara RT; Coelho EAF; da Costa Rocha MO
    Tuberculosis (Edinb); 2024 Jul; 147():102505. PubMed ID: 38583359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of the ML Flow serologic test to slit skin smear.
    Lyon S; Castorina da Silva R; Lyon AC; Grossi MA; Lyon SH; Azevedo Mde L; Bührer-Sékula S; Rocha MO
    Rev Soc Bras Med Trop; 2008; 41 Suppl 2():23-6. PubMed ID: 19618071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does nerve examination improve diagnostic efficacy of the WHO classification of leprosy?
    Mehndiratta RC; Patnaik A; John O; Rao PS
    Indian J Dermatol Venereol Leprol; 2008; 74(4):327-30. PubMed ID: 18797051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leprosy: a review of laboratory and therapeutic aspects--part 2.
    Lastória JC; Abreu MA
    An Bras Dermatol; 2014; 89(3):389-401. PubMed ID: 24937811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concordance between expected and observed bacilloscopy results of clinical forms of leprosy: a 6-year retrospective study in Recife, State of Pernambuco, Brazil.
    Cavalcanti AA; Lucena-Silva N; Montarroyos UR; Albuquerque PM
    Rev Soc Bras Med Trop; 2012 Oct; 45(5):616-9. PubMed ID: 23152346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serologic follow-up of IgG responses against recombinant mycobacterial proteins ML0405, ML2331 and LID-1 in a leprosy hyperendemic area in Venezuela.
    Rada E; Duthie MS; Reed SG; Aranzazu N; Convit J
    Mem Inst Oswaldo Cruz; 2012 Dec; 107 Suppl 1():90-4. PubMed ID: 23283459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.